SCHEMBL20726732

SCHEMBL20726732

N#Cc1ccc2oc3ccc(-c4nc(-c5ccc6ccc7cccnc7c6n5)nc(-c5ccc6ccc7cccnc7c6n5)n4)cc3c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 2/20 0.39
CYP17A1 P05093 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
PDE4D Q08499 2/20 0.37
PDE4A P27815 1/20 0.37
PDE4C Q08493 1/20 0.37
CLK4 Q9HAZ1 1/20 0.36
FABP1 P07148 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PIM1 P11309 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
PIM3 Q86V86 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
GMNN O75496 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21395739 0.92 SLC40A1 (0.41) SLC40A1CYP17A1CYP11B1CYP11B2PDE4D
SCHEMBL21395744 0.90 CYP11B2 (0.41) SLC40A1CYP17A1CYP11B1CYP11B2PDE4D
SCHEMBL21395748 0.90 CYP11B2 (0.41) SLC40A1CYP17A1CYP11B1CYP11B2PDE4D
SCHEMBL21395746 0.89 CYP11B1 (0.45) SLC40A1CYP17A1CYP11B1CYP11B2PDE4D
SCHEMBL21395749 0.88 CYP17A1 (0.42) SLC40A1CYP17A1CYP11B1CYP11B2PDE4D
SCHEMBL21395745 0.87 SLC40A1 (0.40) SLC40A1CYP17A1CYP11B1CYP11B2PDE4D
SCHEMBL20726731 0.85 MAPT (0.41) PDE4DKDM4EMEN1KMT2AGMNN
SCHEMBL20732550 0.84 KDM4E (0.44) SLC40A1CYP17A1CYP11B1CYP11B2PDE4D
SCHEMBL20726738 0.82 CYP11B2 (0.44) SLC40A1CYP17A1CYP11B1CYP11B2PDE4D
SCHEMBL15581935 0.81 CCR1 (0.47) PDE4DCLK4KDM4EGMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 US disclosed
EP-3441391-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2019-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, CYP1A1, CRY1 SLC40A1 1445/4885CYP17A1 1689/4885CYP11B1 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.